​

Funding Round

Series B - Bionaut Labs

Series B - Bionaut Labs

Investment Firm

Overview

Bionaut Labs revolutionizes the treatment of central nervous system disorders with its precision medicine treatment modality.

Announced Date

Nov 28, 2022

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Khosla Ventures

Khosla Ventures

Khosla Ventures is a early_stage_venture and late_stage_venture and post_ipo and seed and venture firm.

Participant Investors

14

Investor Name
Participant InvestorOurCrowd
Participant InvestorBold Capital Partners
Participant InvestorRevolution
Participant InvestorUpfront Ventures
Participant InvestorKhosla Ventures

Round Details and Background

Bionaut Labs raised $43200000 on 2022-11-28 in Series B

Bionaut Labs revolutionizes the treatment of central nervous system disorders with its precision medicine treatment modality.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 12, 2021
Series B - Bionaut Labs
3-undefined
Mar 16, 2022
Series B - Bionaut Labs
1-undefined
Nov 28, 2022
Series B - Bionaut Labs
15-43.2M
May 14, 2024
Series B - Bionaut Labs
1-undefined

Recent Activity

There is no recent news or activity for this profile.